HESG Health Sciences Group Inc (CE)

Health Sciences Group, Inc. (OTCBB:HESG), provider of innovative health and wellness products, announced that a 30-minute television infomercial for its Sequesterol(TM) Advanced Cardio Formula nutritional supplement is planned to broadcast in test markets nationwide from September 7 through 13. Cities slated for the test include Cleveland, Indianapolis, Los Angeles, New York, San Francisco and Philadelphia, as well as national cable networks such as Fox and the Healthy Living Channel (HLC). Broader placement is planned following the evaluation period. A complete broadcast schedule for the infomercial is available at www.Sequesterol.com. Sequesterol includes vital nutrients which support cardiovascular health and help maintain a free-flowing circulatory system(a). This proprietary formulation is based on a unique combination of clinically-studied ingredients known to maintain healthy cholesterol levels, reduce the formation of plaque and protect against heart attack(a). According to the American Heart Association, heart disease affects 1-in-3 adults and claims a life every 33 seconds. (a)Statements relating to the health effects of Sequesterol have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. About Health Sciences Group Health Sciences Group is dedicated to developing and acquiring unique and innovative products that support and enhance a "healthstyle" with a focus on nutrition, wellness and functional well-being. For more information, visit www.HealthSciencesGroup.com and www.Sequesterol.com. This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although the Company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including without limitation, the independent authority of the special committee to act on the matters discussed, the successful negotiation of the potential acquisition and disposal of transactions described above, successful implementation of the company's business strategy and competition, any of which may cause actual results to differ materially from those described in the statements. In addition, other factors that could cause actual results to differ materially are discussed in the Company's most recent Form 10-QSB and Form 10-KSB filings with the Securities and Exchange Commission.